Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD
ENDED JUNE 30, 2003

OR

[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD
FROM
____________ TO ____________

COMMISSION FILE NUMBER 000-26124

IXYS CORPORATION

(Exact name of registrant as specified in its charter)
     
DELAWARE   77-0140882
(State or other jurisdiction
of incorporation or organization)
  (IRS Employer Identification No.)

3540 BASSETT STREET
SANTA CLARA, CALIFORNIA 95054-2704

(Address of principal executive offices and Zip Code)

(408) 982-0700
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes   [X]    No   [_]

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes   [X]    No   [_]

THE NUMBER OF SHARES OF THE REGISTRANT’S COMMON STOCK, $0.01 PAR VALUE, OUTSTANDING AS OF AUGUST 8, 2003, WAS 31,900,413.

 


TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
RISK FACTORS
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 4. CONTROLS AND PROCEDURES.
PART II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
ITEM 5. OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
SIGNATURES
EXHIBIT INDEX
EXHIBIT 31.1
EXHIBIT 32.1


Table of Contents

IXYS CORPORATION

FORM 10-Q
June 30, 2003

INDEX

       
      Page No.
     
PART I — FINANCIAL INFORMATION
   
ITEM 1. FINANCIAL STATEMENTS
  3
 
CONDENSED CONSOLIDATED BALANCE SHEETS
  3
 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
  4
 
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
  5
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
  6
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
  7
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
  14
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
  28
ITEM 4. CONTROLS AND PROCEDURES
  28
PART II – OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS
  30
ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS
  31
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
  31
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
  31
ITEM 5. OTHER INFORMATION
  31
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
  31
SIGNATURES
  32

2


Table of Contents

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

IXYS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

                         
            June 30,   March 31,
            2003   2003
           
 
            (unaudited)
ASSETS
Current assets:
               
Cash and cash equivalents
  $ 41,733     $ 40,094  
Restricted cash
    2,628       2,748  
Accounts receivable, net of allowance for doubtful accounts of $3,582 at June 30, 2003 and $3,169 at March 31, 2003
    23,234       21,475  
Inventories
    51,217       49,162  
Prepaid expenses and other current assets
    960       943  
Deferred income taxes
    10,172       10,285  
 
   
     
 
 
Total current assets
    129,944       124,707  
Plant and equipment, net
    28,249       28,715  
Other assets
    5,642       5,655  
Deferred income taxes
    2,789       2,563  
Goodwill
    21,417       21,417  
 
   
     
 
 
Total assets
  $ 188,041     $ 183,057  
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
Current portion of capitalized lease obligations
  $ 3,490     $ 3,238  
Current portion of notes payable to bank
    800       700  
Accounts payable
    14,099       11,177  
Accrued expenses and other liabilities
    14,920       14,167  
 
   
     
 
 
Total current liabilities
    33,309       29,282  
Capitalized lease and other long-term obligations, net of current portion
    4,397       5,042  
Pension liabilities
    10,523       9,924  
 
   
     
 
 
Total liabilities
    48,229       44,248  
 
   
     
 
Commitments and contingencies (Note 11)
               
Stockholders’ Equity
               
 
Preferred stock, $0.01 par value:
               
 
Authorized: 5,000,000 shares; none issued and outstanding
               
 
Common stock, $0.01 par value:
               
 
Authorized: 80,000,000 shares issued and outstanding: 31,994,586 shares at June 30, 2003 and 31,957,182 shares at March 31, 2003
    320       320  
Additional paid-in capital
    145,085       144,835  
Deferred compensation
    (18 )     (26 )
Notes receivable from stockholders
    (913 )     (913 )
Accumulated deficit
    (5,875 )     (6,318 )
Less cost of treasury stock: 95,302 shares at June 30, 2003 and at March 31, 2003
    (447 )     (447 )
Accumulated other comprehensive income
    1,660       1,358  
 
   
     
 
 
Total stockholders’ equity
    139,812       138,809  
 
   
     
 
   
Total liabilities and stockholders’ equity
  $ 188,041     $ 183,057  
 
   
     
 

The accompanying notes are an integral part of these condensed consolidated
financial statements.

3


Table of Contents

IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

                       
          Three Months Ended
          June 30,
         
          2003   2002
         
 
          (unaudited)
Net revenues
  $ 40,096     $ 27,437  
Cost of goods sold
    27,755       21,061  
 
   
     
 
     
Gross profit
    12,341       6,376  
 
   
     
 
Operating expenses:
               
   
Research, development and engineering
    4,035       2,186  
   
Selling, general and administrative
    6,489       5,205  
 
   
     
 
     
Total operating expenses
    10,524       7,391  
 
   
     
 
   
Operating income (loss)
    1,817       (1,015 )
Interest income
    112       203  
Interest expense
    (36 )     (39 )
Other (expense) income, net
    (1,211 )     (1,352 )
 
   
     
 
 
Income (loss) before income tax benefit (provision)
    682       (2,203 )
 
Benefit from (provision for) income tax
    (239 )     785  
 
   
     
 
Net income (loss)
  $ 443     $ (1,418 )
 
   
     
 
Net income (loss) per share — basic
  $ 0.01     $ (0.05 )
 
   
     
 
Weighted average shares used in per share calculation — Basic
    31,972       27,999  
 
   
     
 
Net income (loss) per share — diluted
  $ 0.01     $ (0.05 )
 
   
     
 
Weighted average shares used in per share calculation — Diluted
    33,116       27,999  
 
   
     
 

The accompanying notes are an integral part of these condensed consolidated
financial statements.

4


Table of Contents

IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

                   
      Three Months Ended
      June 30,
     
      2003   2002
     
 
      (unaudited)
Net income (loss)
    $443     $ (1,418 )
Other comprehensive income:
                     
 
Foreign currency translation adjustments
    302       2,974  
 
   
     
 
 
Comprehensive income
    $745     $ 1,556  

The accompanying notes are an integral part of these condensed consolidated
financial statements.

5


Table of Contents

IXYS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

                     
        Three Months Ended
        June 30,
       
        2003   2002
       
 
        (unaudited)
Cash flows from operating activities:
               
Net income (loss)
  $ 443     $ (1,418 )
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
               
Depreciation
    2,141       1,409  
Amortization of intangible assets
    212       90  
Provision for doubtful accounts
    390       291  
Deferred income taxes
    (174 )     (1,039 )
Gain (loss) on foreign currency transactions
    (485 )     38  
Changes in operating assets and liabilities :
               
   
Accounts receivable
    (1,340 )     (1,307 )
   
Inventories
    (1,968 )     3,268  
   
Prepaid expenses and other current assets
    43       (986 )
   
Other assets
    (355 )     (889 )
   
Accounts payable
    2,524       1,246  
   
Accrued expenses and other liabilities
    469       (759 )
   
Pension liabilities
    833       123  
 
   
     
 
 
Net cash provided by operating activities
    2,733       67  
 
   
     
 
Cash flows from investing activities:
               
Restricted cash
    120       (114 )
Net cash acquired in acquisition of Clare, Inc.
          7,906  
Cash received for tax refund claims acquired from Clare, Inc.
          2,500  
Purchase of plant and equipment
    (1,271 )     (63 )
 
   
     
 
 
Net cash provided by (used in) investing activities
    (1,151 )     10,229  
 
   
     
 
Cash flows from financing activities:
               
Proceeds from capital lease obligations
    210        
Principal payments on capital lease obligations
    (784 )     (722 )
Proceeds from exercise of options
    74       68  
Proceeds from issuance of shares under ESPP
    181       112  
 
   
     
 
 
Net cash used in financing activities
    (319 )     (542 )
 
   
     
 
Effect of foreign exchange rate fluctuations on cash and cash equivalents
    376       986  
 
   
     
 
Net increase in cash and cash Equivalents
    1,639       10,740  
Cash and cash equivalents at beginning of period
    40,094       32,111  
 
   
     
 
Cash and cash equivalents at end of period
  $ 41,733     $ 42,851  
 
   
     
 

The accompanying notes are an integral part of these condensed consolidated
financial statements.

6


Table of Contents

IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.     Condensed Consolidated Financial Statements

     The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The condensed consolidated financial statements include the accounts of IXYS Corporation (“IXYS” or the “Company”) and its wholly-owned subsidiaries. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most difficult judgments include: assessment of recoverability of goodwill, valuation of property, plant and equipment, valuation of inventory, and the recognition and measurement of income tax assets and liabilities. All significant intercompany transactions have been eliminated in consolidation. All adjustments of a normal recurring nature that, in the opinion of management, are necessary for a fair statement of the results for the interim periods have been made. It is recommended that the interim financial statements be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended March 31, 2003 contained in the Company’s Annual Report on Form 10-K. Interim results are not necessarily indicative of the operating results expected for later quarters or the full fiscal year. Certain reclassifications have been made to the prior period’s condensed consolidated financial statements to conform to the current period’s presentation. Such reclassifications had no effect on previously reported results of operations or retained earnings.

2.     Warranty

     The Company generally sells products with a limited warranty of product quality and a limited indemnification of customers against intellectual property infringements claims related to the Company’s products. The Company accrues for known warranty and indemnification issues if a loss is probable and can be reasonably estimated, and accrues for estimated but incurred and unidentified issues based on historical activity. Actual warranty costs incurred have not materially differed from those accrued. IXYS’s warranty policy is effective for shipped products which are considered defective or fail to meet the product specifications. IXYS analyzes historical claims compared to historical revenue in evaluating the adequacy of the warranty allowance. Warranty costs are reflected in the income statement as a cost of revenues. There was no material change in the warranty provision for the three month period ending June 30, 2003.

3.     Accounting for Stock-Based Compensation

     The Company has a stock option plan under which officers, key employees and non-employee directors may be granted options to purchase shares of the Company’s authorized but unissued common stock. Options granted by IXYS currently expire no later than 10 years from the grant date. Currently, options granted to existing and newly hired employees generally vest in increments over four years from the date of grant. In addition to the stock option plans, the Company also has an Employee Stock Purchase Plan, under which eligible employees may purchase shares of IXYS’s common stock at 85% of fair market value at specific, predetermined dates.

     Statement of Financial Accounting Standards No. 148, “Accounting for Stock-Based Compensation – Transition and Disclosure, an Amendment of FASB Statement No. 123” (“SFAS No. 148”) provides alternative methods of transition for companies making a voluntary change to fair value-based accounting for stock-based employee compensation. SFAS No. 148 also requires disclosure of pro-forma results on a quarterly basis as if the company had applied the fair value recognition provisions of SFAS No. 123. IXYS continues to account for its stock option plans under the intrinsic value recognition and measurement principles of APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and related Interpretations.

As the exercise price of all options granted under these plans was equal to the market price of the underlying common stock on the grant date, no stock-based employee compensation, other than acquisition-related compensation, is recognized in net income. The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of SFAS No. 123, as amended, to options granted under the stock option plans and rights to acquire stock granted under the Company’s Employee Stock Purchase Plan, collectively called “options.” For purposes of this pro-forma disclosure, the value of the options is estimated using a Black-Scholes option pricing model and amortized ratably to expense over the options’ vesting periods. Because the estimated value is determined as of the date of grant, the actual value ultimately realized by the employee may be significantly different.

7


Table of Contents

IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                 
    Three Months Ended June 30,
   
    2003   2002
   
 
    (in thousands, except share data)
(unaudited)
Net Income (loss), as reported
  $ 443     $ (1,418 )
Less: Total stock based compensation expense determined under fair value based method for all awards to employees
    (238 )     (128 )
 
   
     
 
Pro forma net income (loss)
  $ 205     $ (1,546 )
 
   
     
 
Basic and diluted net income (loss) per share:
               
As reported
  $ 0.01     $ (0.06 )
 
   
     
 
Pro forma
  $ 0.01     $ (0.06 )
 
   
     
 

SFAS No. 123 requires the use of option pricing models that were not developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. Because the Company’s employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in the opinion of management, the existing models do not necessarily provide a reliable single measure of the fair value of employee stock options.

4.     Acquisition of Clare, Inc.

     On June 10, 2002, IXYS completed its acquisition of Clare, Inc. (“Clare”), a manufacturer of high-performance analog and mixed-signal integrated circuits based in the United States. The acquisition of Clare was intended to allow the combined organization to be more competitive and to achieve greater financial strength, operational efficiencies, access to capital and growth potential than either company could separately achieve. In connection with the acquisition, (a) each outstanding share of Clare common stock was converted into the right to receive 0.49147 of a share of IXYS common stock, which resulted in the issuance of approximately 4.89 million shares of IXYS common stock, and (b) each option to purchase Clare common stock outstanding immediately prior to the consummation of the acquisition was converted into an option to purchase 0.49147 of a share of IXYS common stock, resulting in the assumption of options exercisable for approximately 1.0 million shares of IXYS common stock. The estimated total purchase price is as follows (in thousands):

           
Value of IXYS common stock issued
  $ 47,658  
Value of Clare’s options assumed by IXYS
    3,679  
Merger cost
    1,738  
 
   
 
 
Total purchase price
  $ 53,075  
 
   
 

     IXYS has finalized the fair values of identifiable intangible assets acquired and plant and equipment. Replacement cost has been used to determine the fair value of the plant and equipment acquired. IXYS has allocated the purchase price to identifiable intangible assets, tangible assets, liabilities assumed and goodwill as follows (in thousands):

           
Value of IXYS common stock issued
  $ 47,658  
Value of Clare’s options assumed by IXYS
    3,679  
Merger cost
    1,738  
 
   
 
 
Total purchase price
  $ 53,075  
 
   
 
Fair Value of tangible assets acquired:
       
 
Current assets
  $ 24,861  
 
Deferred tax assets — short term
    2,742  
 
Plant and equipment
    10,271  
 
Other assets
    111  
 
   
 
 
  $ 37,985  
                   
Amortizable intangible assets:           Estimated Useful Lives

         
 
Core technology
    2,700     5 to 6 years
 
Tradename/trademarks
    900     3 years
 
Other
    715     3 months to 6 years
 
   
         
 
    4,315          
Total assets acquired
    42,300          

8


Table of Contents

IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

           
Fair value of liabilities assumed
    (8,746 )
 
   
 
Net assets acquired
    33,554  
Goodwill
    19,521  
 
   
 
 
Total purchase price
  $ 53,075  

Pro Forma Disclosure (in thousands, except per share data):

     The following unaudited pro forma combined amounts give effect to the acquisition of Clare as if the acquisition had occurred on April 1, 2002. On a pro forma basis, the results of operations of Clare for the three-month period ended June 30, 2002 are consolidated with IXYS results for the three-month period ended June 30, 2002. The pro forma amounts do not purport to be indicative of what would have occurred had the acquisition been made as of the beginning of the period or of results which may occur in the future.

         
    Three Months Ended
    June 30, 2002
   
Revenue
  $ 33,893  
Net loss
    (9,201 )
Net loss per share — basic and diluted
  $ (0.29 )
Shares used in per share calculation
    31,817  

5.     New and Recently Effective Accounting Pronouncements

     In January 2003, the FASB issued FIN 46, “Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51.” FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective immediately for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provision of FIN 46 must be applied for the first interim or annual period beginning after June 15, 2003. The Company believes that the adoption of this standard will have no material impact on its financial statements.

     In April 2003, the FASB issued SFAS No. 149, “Amendment of Statement 133 of Derivative Instruments and Hedging Activities.” SFAS No. 149 amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts. This standard is effective for contracts entered into or modified after June 30, 2003. IXYS adopted this standard and the adoption of this standard had no material impact on its financial statements.

9


Table of Contents

IXYS CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     In May 2003, the FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” SFAS No. 150 establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. SFAS No. 150 is to be implemented by reporting the cumulative effect of a change in an accounting principle for financial instruments created before the issuance date of the statement and still existing at the beginning of the interim period of adoption. The Company does not expect the adoption of SFAS No. 150 to have a significant impact on its financial position or results of operations.

8.     Inventories

Inventories consist of the following (in thousands):

                 
    June 30,   March 31,
    2003   2003
   
 
    (unaudited)
Raw materials
  $ 8,184     $ 8,765  
Work in process
    29,639       31,842  
Finished goods
    13,394